Cell Genesys Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives
Cell Genesys, Inc. reported that over 98% or approximately $67 million aggregate principal amount of its 3.125% convertible bonds were tendered in its previously announced exchange offer. The Company offered to exchange all of the $68.3 million aggregate principal amount of its outstanding 3.125% Convertible Senior Notes due in 2011 at a purchase price for each $1,000 principal amount of $500, plus accrued interest, $140 worth of common stock equal to approximately 221 shares of common stock, and $310 of new 3.125% Convertible Senior Notes due in May 2013. [more...]
|
|
|
